Financials
- Market Capitalization 4.49 M
- Employee 1
- Founded 2020
- CEO N/A
- Website liminatuspharma.com
- Headquarter Delaware, United States
- FIGI BBG01HVYG111
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4998 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.21 USD | +4.31% | +6.14% | 0.00% | -61.22% | 4.60 M USD | ||
| 4999 | MBIO Mustang Bio, Inc. - Common Stock | 0.66 USD | 0.00% | -7.04% | -9.59% | -23.96% | 4.78 M USD | ||
| 5003 | FBLG FibroBiologics, Inc. - Common Stock | 0.87 USD | +1.16% | +3.57% | -5.43% | +33.85% | 4.53 M USD | ||
| 5011 | CANF Can-Fite Biopharma Ltd American Depositary Shares, each represe | 3.19 USD | -1.54% | -6.18% | +6.69% | -26.75% | 4.18 M USD |